<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24329688</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2567</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Immunology</Title><ISOAbbreviation>Immunology</ISOAbbreviation></Journal><ArticleTitle>Dominant CD4-dependent RNA-dependent RNA polymerase-specific T-cell responses in children acutely infected with human enterovirus 71 and healthy adult controls.</ArticleTitle><Pagination><StartPage>89</StartPage><EndPage>100</EndPage><MedlinePgn>89-100</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/imm.12235</ELocationID><Abstract><AbstractText>Human enterovirus 71 (EV71) is one of the major causes of hand, foot and mouth disease (HFMD), which leads to significant mortality in infected children. A prophylactic vaccine is urgently needed. However, little is known about the protective T-cell immunity in individuals infected with the EV71 virus. In this study, we performed a comprehensive ex vivo interferon-&#x3b3; ELISPOT analysis in 31 children infected with EV71 as well as in 40 healthy adult controls of the CD4(+) and CD8(+) T-cell responses to overlapping peptides spanning the VP1 structural protein and RNA-dependent RNA polymerase (RdRp) non-structural protein. EV71-specific CD4 T-cell responses were detected in most of the acute patients and were mostly CD4-dependent RdRp-specific responses. CD8-dependent VP1 and RdRp-specific responses were also detected in a small proportion of recently infected children. There was no significant association between the strength of the T-cell responses and disease severity observed during the acute EV71 infection phase. Interestingly, an RdRp-specific, but no VP1-specific, CD4-dependent T-cell response was detected in 30% of the adult controls, and no T-cell responses were detected in healthy children. In addition, 24 individual peptides containing potential T-cell epitope regions were identified. The data suggest that CD4-dependent RdRp-specific T-cell responses may play an important role in protective immunity, and the epitopes identified in this study should provide valuable information for future therapeutic and prophylactic vaccine design as well as basic research.</AbstractText><CopyrightInformation>&#xa9; 2013 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Shuangsuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The Second Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, China; Department of Epidemiology and Biostatistics, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ning</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yaping</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mei</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiufang</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Xiaoli</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Zhai</LastName><ForeName>Song</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xin</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jingkun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Huiling</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Tao</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G0600520</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1001046</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L018942/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immunology</MedlineTA><NlmUniqueID>0374672</NlmUniqueID><ISSNLinking>0019-2805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C442501">VP1 protein, Foot-and-mouth disease virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058501" MajorTopicYN="N">Enzyme-Linked Immunospot Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018604" MajorTopicYN="N">Epitope Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007111" MajorTopicYN="Y">Immunity, Cellular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059425" MajorTopicYN="N">Interferon-gamma Release Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012324" MajorTopicYN="N">RNA-Dependent RNA Polymerase</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">T-cell-mediated immunity</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">enzyme-linked immunospot assays</Keyword><Keyword MajorTopicYN="N">epitopes</Keyword><Keyword MajorTopicYN="N">overlapping peptides</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24329688</ArticleId><ArticleId IdType="pmc">PMC3992051</ArticleId><ArticleId IdType="doi">10.1111/imm.12235</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardoso MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bek EJ, McMinn PC. Recent advances in research on human enterovirus 71. Future Virol. 2010;5:453&#x2013;68.</Citation></Reference><Reference><Citation>Lee T-C, Guo H-R, Su H-JJ, Yang Y-C, Chang H-L, Chen K-T. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J. 2009;28:904&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">20118685</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-V&#xe9;lez CM, Anderson MS, Robinson CC, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis. 2007;45:950.</Citation><ArticleIdList><ArticleId IdType="pubmed">17879907</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoades RE, Tabor-Godwin JM, Tsueng G, Feuer R. Enterovirus infections of the central nervous system. Virology. 2011;411:288&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3060663</ArticleId><ArticleId IdType="pubmed">21251690</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang SS, Li M, Gao N, Wang XF, Li YP, Jia XL, Wang Y. Clinical feature of 36 critical cases of hand foot and mouth disease. Int J Infect Dis. 2011;15:S41&#x2013;2.</Citation></Reference><Reference><Citation>Wu KX, Ng MM, Chu JJ. Developments towards antiviral therapies against enterovirus 71. Drug Discov Today. 2010;15:1041&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108380</ArticleId><ArticleId IdType="pubmed">20974282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang DM, Lu JY, Lu JH. Enterovirus 71 vaccine: close but still far. Int J Infect Dis. 2010;14:E739&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110504</ArticleId><ArticleId IdType="pubmed">20400350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Feng ZJ, Yang Y, et al. Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology. 2011;22:781&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3246273</ArticleId><ArticleId IdType="pubmed">21968769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Hsiung CA, Lu CY, et al. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res. 2006;60:466&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7086547</ArticleId><ArticleId IdType="pubmed">16940249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Chang KC, Kao CM, Chang SP, Tung YY, Chen SH. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J Virol. 2009;83:6477&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Wang SW, Tung YY, Chen SH. Enterovirus 71 infection of human dendritic cells. Exp Biol Med (Maywood) 2009;234:1166&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">19596831</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang KD, Yang MY, Li CC, et al. Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J Infect Dis. 2001;183:850&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11237800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang KJ, et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003;188:564&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang SS, Gao N, Li M. The pathogenesis during enterovirus 71-induced HFMD. Int J Infect Dis. 2011;15:S108.</Citation></Reference><Reference><Citation>Bae JY, Moon SH, Choi JA, et al. Recombinant DNA and protein vaccines for foot-and-mouth disease induce humoral and cellular immune responses in mice. Immune Netw. 2009;9:265&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2816960</ArticleId><ArticleId IdType="pubmed">20157614</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham S, Wang EC, Jenkins O, Borysiewicz LK. Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J Virol. 1993;67:1627&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC237534</ArticleId><ArticleId IdType="pubmed">7679749</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Weng L, Zhang N, Arita M, Li R, Chen L, Toyoda T. Biochemical characterization of enterovirus 71 3D RNA polymerase. Biochim Biophys Acta. 2011;1809:211&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21220056</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. Crystal structure of human enterovirus 71. Science. 2012;336:1274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AA, Peersen OB. Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J. 2004;23:3462&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC516629</ArticleId><ArticleId IdType="pubmed">15306852</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagnola G, Weygandt M, Scoggin K, Peersen O. Crystal structure of coxsackievirus B3 3Dpol highlights the functional importance of residue 5 in picornavirus polymerases. J Virol. 2008;82:9458&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2546958</ArticleId><ArticleId IdType="pubmed">18632862</ArticleId></ArticleIdList></Reference><Reference><Citation>Love RA, Maegley KA, Yu X, et al. The crystal structure of the RNA-dependent RNA polymerase from human rhinovirus: a dual function target for common cold antiviral therapy. Structure. 2004;12:1533&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">15296746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Orta C, Arias A, Perez-Luque R, Escarm&#xed;s C, Domingo E, Verdaguer N. Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J Biol Chem. 2004;279:47212&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">15294895</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao KC, Chan EC, Chang LY, et al. Responses of IgM for enterovirus 71 infection. J Med Virol. 2002;68:574&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">12376966</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Yan Q, Wang H, et al. Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS ONE. 2010;5:e11388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2894942</ArticleId><ArticleId IdType="pubmed">20613983</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. 2008. pp. 1&#x2013;25. Report on the Hand, Foot and Mouth Disease Outbreak in Fuyang City, Anhui Province and the Prevention and Control in China.</Citation></Reference><Reference><Citation>Lee LYH, Ha DLA, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest. 2008;118:3478&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2542885</ArticleId><ArticleId IdType="pubmed">18802496</ArticleId></ArticleIdList></Reference><Reference><Citation>Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol. 2003;77:2081&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140965</ArticleId><ArticleId IdType="pubmed">12525643</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JH, Ferrari G, Kalams SA, Lopaczynski W, Oden N, D'Souza MP. Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. AIDS Res Hum Retroviruses. 2005;21:68&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">15665646</ArticleId></ArticleIdList></Reference><Reference><Citation>Streeck H, Frahm N, Walker BD. The role of IFN-&#x3b3; Elispot assay in HIV vaccine research. Nat Protoc. 2009;4:461&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19282851</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson TM, Li CK, Chui CS, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;18:274&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22286307</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H, Xu-xiang L, Li-ye Z, et al. Hand, foot and mouth disease severe cases score criteria receiver operation characteristic curve. Chinese J Epidemiol. 2010;31:563&#x2013;6.</Citation></Reference><Reference><Citation>Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">3287615</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy PL, Sharpe MR, Spiesel SZ, et al. Observation scales to identify serious illness in febrile children. Pediatrics. 1982;70:802&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7133831</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DGW, Macary PA, Alonso S, Poh CL. Identification of human CD4+ T-cell epitopes on the VP1 capsid protein of enterovirus 71. Viral Immunol. 2008;21:215&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">18419256</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308517</ArticleId><ArticleId IdType="pubmed">7984417</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Tan XJ, Wang HY, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 2009;44:262&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19269888</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Tsao KC, Hsia SH, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 2004;291:222&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">14722149</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Ma XJ, Xu WB, et al. EV71 viral secretion by symptomatic hand foot and mouth disease patients and their asymptomatic close contacts. J Infect. 2011;62:107&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21087628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaoutis T, Klein JD. Enterovirus infections. Pediatr Rev. 1998;19:183&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">9613170</ArticleId></ArticleIdList></Reference><Reference><Citation>Juhela S, Hy&#xf6;ty H, L&#xf6;nnrot M, Roivainen M, Simell O, Ilonen J. Enterovirus infections and enterovirus specific T-cell responses in infancy. J Med Virol. 1998;54:226&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">9515773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Lou Z, Miao Y, et al. Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein cell. 2010;1:491&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4875138</ArticleId><ArticleId IdType="pubmed">21203964</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLeod MKL, Clambey ET, Kappler JW, Marrack P. CD4 memory T cells: what are they and what can they do? Semin Immunol. 2009;21:53&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2679806</ArticleId><ArticleId IdType="pubmed">19269850</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun JC, Williams MA, Bevan MJ. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol. 2004;5:927&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2776074</ArticleId><ArticleId IdType="pubmed">15300249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal SK, Kumar P, Yeo WM, Kar-Roy A, Chow VT. The VP1 protein of human enterovirus 71 self-associates via an interaction domain spanning amino acids 66&#x2013;297. J Med Virol. 2006;78:582&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">16555287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, Yang KD. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr. 2002;91:632&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F, Wang YP, Mao QY, et al. Enterovirus 71 viral capsid protein linear epitopes: identification and characterization. Virol J. 2012;9:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3292509</ArticleId><ArticleId IdType="pubmed">22264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DGW, Alonso S, Chow VTK, Poh CL. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect. 2007;9:1299&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">17890123</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DGW, Ang RX, Alonso S, Chow VTK, Quak SH, Poh CL. Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots. Clin Microbiol Infect. 2008;14:286&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18076666</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DGW, Alonso S, Phoon MC, Ramachandran NP, Chow VTK, Poh CL. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 2007;125:61&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17222936</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>